Unidoc Health Corp.
UDOCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $233 | $134 | $0 | $0 |
| % Growth | 73.8% | – | – | – |
| Cost of Goods Sold | $193 | $63 | $0 | $0 |
| Gross Profit | $40 | $71 | $0 | $0 |
| % Margin | 17.1% | 52.7% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $577 | $674 | $458 |
| SG&A Expenses | $619 | $620 | $703 | $1,463 |
| Sales & Mktg Exp. | $0 | $43 | $28 | $1,006 |
| Other Operating Expenses | $0 | $129 | $54 | $61 |
| Operating Expenses | $619 | $749 | $757 | $1,524 |
| Operating Income | -$579 | -$679 | -$757 | -$1,524 |
| % Margin | -248.4% | -506.2% | – | – |
| Other Income/Exp. Net | -$50 | $36 | -$231 | -$16 |
| Pre-Tax Income | -$629 | -$642 | -$988 | -$1,540 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$629 | -$642 | -$988 | -$1,540 |
| % Margin | -269.8% | -479.3% | – | – |
| EPS | -0.008 | -0.006 | -0.014 | -0.025 |
| % Growth | -33.9% | 56.6% | 42.6% | – |
| EPS Diluted | -0.008 | -0.006 | -0.014 | -0.025 |
| Weighted Avg Shares Out | 76,350 | 76,350 | 69,074 | 61,798 |
| Weighted Avg Shares Out Dil | 76,350 | 76,350 | 69,074 | 61,798 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $96 | $1 |
| Depreciation & Amortization | $32 | $44 | $10 | $10 |
| EBITDA | -$595 | -$597 | -$882 | -$1,530 |
| % Margin | -255.2% | -445% | – | – |